EMAIL THIS PAGE TO A FRIEND

Nanoscale

Surface coating of siRNA-peptidomimetic nano-self-assemblies with anionic lipid bilayers: enhanced gene silencing and reduced adverse effects in vitro.


PMID 26553270

Abstract

Cationic vectors have demonstrated the potential to facilitate intracellular delivery of therapeutic oligonucleotides. However, enhanced transfection efficiency is usually associated with adverse effects, which also proves to be a challenge for vectors based on cationic peptides. In this study a series of proteolytically stable palmitoylated α-peptide/β-peptoid peptidomimetics with a systematically varied number of repeating lysine and homoarginine residues was shown to self-assemble with small interfering RNA (siRNA). The resulting well-defined nanocomplexes were coated with anionic lipids giving rise to net anionic liposomes. These complexes and the corresponding liposomes were optimized towards efficient gene silencing and low adverse effects. The optimal anionic liposomes mediated a high silencing effect, which was comparable to that of the control (cationic Lipofectamine 2000), and did not display any noticeable cytotoxicity and immunogenicity in vitro. In contrast, the corresponding nanocomplexes mediated a reduced silencing effect with a more narrow safety window. The surface coating with anionic lipid bilayers led to partial decomplexation of the siRNA-peptidomimetic nanocomplex core of the liposomes, which facilitated siRNA release. Additionally, the optimal anionic liposomes showed efficient intracellular uptake and endosomal escape. Therefore, these findings suggest that a more efficacious and safe formulation can be achieved by surface coating of the siRNA-peptidomimetic nano-self-assemblies with anionic lipid bilayers.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

AV41929
Anti-CD40 antibody produced in rabbit, affinity isolated antibody
HPA031567
Anti-CD40 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA031568
Anti-CD40 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2103449
Anti-CD40, (N-terminal) antibody produced in rabbit, affinity isolated antibody
SAB4503674
Anti-CD40, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB1411654
Anti-CD86 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
WH0000958M1
Monoclonal Anti-CD40 antibody produced in mouse, clone 1G1, purified immunoglobulin, buffered aqueous solution
AMAB90905
Monoclonal Anti-CD40 antibody produced in mouse, Prestige Antibodies® Powered by Atlas Antibodies, clone CL1673, purified immunoglobulin, buffered aqueous glycerol solution
WH0000942M1 Monoclonal Anti-CD86 antibody produced in mouse, clone 3D7, purified immunoglobulin, buffered aqueous solution
SAB4700144 Monoclonal Anti-CD86 antibody produced in mouse, clone BU63, purified immunoglobulin, buffered aqueous solution
SAB4700560 Monoclonal Anti-Cd86 antibody produced in rat, clone GL-1, purified immunoglobulin, buffered aqueous solution
P13207
Phenazine, 98%
C12H8N2
P9625
Phenazine methosulfate, ≥90% (UV)
C14H14N2O4S